I don't think we're facing an either/or situation here. As I understand it right now, on April 13, we don't have anything planned. It was going to be a steering committee date. On May 4, there is the pharmacare update from the PBO. I think you just said that if they have sufficient information, then we don't need to meet with the PBO. We have four potential meetings in May, and two more potential meetings in June.
By my tally, we have somewhere between six to eight meetings that we can do. We're talking about four for microbial resistance and probably two for PTSD, and I still think we have some slack left.
There are two openings. If I'm right, April 13 is free. We could hear from Mr. Doherty at that time and have his bill introduced and get an understanding of what we need for witnesses. We could still launch the microbial resistance starting on April 16 and run four weeks of it and get that report finished and done before we break.
It's just a matter of some scheduling here, and we can do both of these and have another two reports before the end of the session.